An HTA (Health Technology Assessment) is a multi-disciplinary field of policy analysis that systematically evaluates the properties and effects of a health technology to inform decision making.

Payer value proposition development and construction involves the testing of potential value messages (VMs) associated with the clinical and economic evidence for a therapeutic and their further development with the client and associated advisors. It is impotant to also have a deep understanding of the potential reimbursement challenges and likely questions that may arise from payers and budget holders.